Ethnicity is an important demographic variable contributing to interindivid
ual variability in drug metabolism and response. In this rapidly expanding
research area many genetic factors that account for the effects of ethnicit
y on pharmacokinetics, pharmacodynamics, and drug safety have been identifi
ed. This review focuses on recent developments that have improved understan
ding of the molecular mechanisms responsible for such interethnic differenc
es. Genetic variations that may provide a molecular basis for ethnic differ
ences in drug metabolizing enzymes (CYP 2C9, 2C19, 2D6, and 3A4), drug tran
sporter (P-glycoprotein), drug receptors (adrenoceptors), and other functio
nally important proteins (eNOS and G proteins) are discussed. A better unde
rstanding of the molecular basis underlying ethnic differences in drug meta
bolism, transport, and response will contribute to improved individualizati
on of drug therapy.